Key Principles and Recommended Regimens for First-line Antiretroviral Therapy
Considerations for Choosing a First-line NNRTI
When choosing among efavirenz, doravirine, and rilpivirine, the latter would be a reasonable option in patients with baseline HIV-1 RNA < 100,000 copies/mL and CD4+ cell count > 200 cells/mm³, where the better tolerability of rilpivirine is not offset by excess risk of virologic failure. Additional considerations for the use of rilpivirine...
Action required
or